Maxygen, International AIDS Vaccine Initiative, Rockefeller Foundation deal

DBLV LLC, which is funded by the Rockefeller Foundation, will provide R&D funding to MAXY for at least three years to expand its ongoing HIV vaccine development program using its MolecularBreeding di...